UAMY · United States Antimony Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.00M | - | $8.70M | $10.53M | $7.00M | - | $2.42M | $2.81M | $2.83M | - |
| Cost of Revenue | $5.67M | - | $6.69M | $7.69M | $4.63M | - | $2.00M | $1.91M | $2.01M | - |
| Gross Profit | $1.11M | - | $2.01M | $2.84M | $2.37M | - | $425.8K | $908.6K | $822.9K | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $1.33M | - | $882.9K | $843.0K | $550.6K | - | $588.8K | $477.4K | $455.4K | - |
| Total Operating Expenses | $8.63M | - | $6.93M | $2.82M | $2.01M | - | $1.27M | $1.12M | $891.6K | - |
| D&A | $410.5K | - | $279.8K | $277.6K | $282.0K | - | $119.6K | $114.5K | $106.1K | - |
| Operating Income | ($7.52M) | - | ($4.92M) | $20.0K | $358.0K | - | ($845.0K) | ($213.6K) | ($68.7K) | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | - | - | $0 | $0 | $0 | - | $0 | $0 | $0 | - |
| Net Income | ($11.29M) | - | ($4.78M) | $181.6K | $546.5K | - | ($727.5K) | $202.8K | ($322.8K) | - |
| EPS - Basic | ($0.08) | - | ($0.04) | - | $0.00 | - | $108438984.00 | $107647317.00 | $107908306.00 | - |
| EPS - Diluted | ($0.08) | - | ($0.04) | - | $0.00 | - | $108438984.00 | $108943126.00 | $107908306.00 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.38M | $30.49M | $18.47M | $5.81M | $18.85M | $18.17M | $12.97M | $12.39M | $11.94M | $11.90M |
| Accounts Receivable | $2.51M | $4.21M | $1.90M | $2.54M | $1.97M | $1.16M | $791.6K | $1.39M | $1.06M | $625.3K |
| Inventory | $22.03M | $12.52M | $8.41M | $6.81M | $3.99M | $1.25M | $966.8K | $462.4K | $653.0K | $1.39M |
| Accounts Payable | $9.67M | $6.92M | $4.22M | $5.75M | $3.21M | $1.55M | $1.21M | $544.1K | $403.4K | $456.9K |
| Current Assets | $48.41M | $54.74M | $31.80M | $17.68M | $24.84M | $20.68M | $15.00M | $14.61M | $14.01M | $14.08M |
| Total Assets | $148.05M | $153.93M | $79.88M | $47.50M | $39.50M | $34.64M | $29.75M | $28.93M | $28.01M | $28.09M |
| Current Liabilities | $13.37M | $10.18M | $6.26M | $8.00M | $4.72M | $4.01M | $2.40M | $1.25M | $906.1K | $897.5K |
| Long-term Debt | $23.5K | $58.5K | $93.2K | $127.5K | $161.6K | $195.4K | $228.9K | $262.1K | $0 | $0 |
| Total Liabilities | $16.15M | $12.97M | $8.13M | $9.99M | $6.91M | $6.04M | $4.63M | $3.23M | $2.60M | $2.57M |
| Stockholders' Equity | $131.89M | $140.96M | $71.75M | $37.51M | $32.59M | $28.60M | $25.13M | $25.70M | $25.40M | $25.52M |
| Retained Earnings | ($56.78M) | ($45.49M) | ($45.20M) | ($40.42M) | ($40.60M) | ($41.15M) | ($40.27M) | ($39.54M) | ($39.74M) | ($39.42M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($12.06M) | - | - | - | ($1.73M) | - | - | - | ($285.2K) | - |
| Investing Cash Flow | ($12.58M) | - | - | - | ($862.0K) | - | - | - | $0 | - |
| Financing Cash Flow | ($2.63M) | - | - | - | ($21.3K) | - | - | - | ($21.3K) | - |
| CapEx | $12.58M | - | - | - | $862.5K | - | - | - | $52.7K | - |
| Free Cash Flow | ($24.64M) | - | - | - | ($2.59M) | - | - | - | ($337.9K) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 15.8% | - | 23.1% | 27.0% | 33.9% | - | 17.6% | 32.3% | 29.1% | - |
| Operating margin | -107.4% | - | -56.5% | 0.2% | 5.1% | - | -34.9% | -7.6% | -2.4% | - |
| EBITDA margin | -101.5% | - | -53.3% | 2.8% | 9.1% | - | -30.0% | -3.5% | 1.3% | - |
| Net margin | -161.3% | - | -54.9% | 1.7% | 7.8% | - | -30.0% | 7.2% | -11.4% | - |
| Free cash flow margin | -352.0% | - | - | - | -37.0% | - | - | - | -11.9% | - |
| FCF / Net income | 2.18 | - | - | - | -4.74 | - | - | - | 1.05 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 19.0% | - | 10.1% | 8.0% | 7.9% | - | 24.3% | 17.0% | 16.1% | - |
| Effective tax rate | - | - | - | 0.0% | 0.0% | - | - | 0.0% | - | - |
| Return on assets | -7.6% | - | -6.0% | 0.4% | 1.4% | - | -2.4% | 0.7% | -1.2% | - |
| Return on equity | -8.6% | - | -6.7% | 0.5% | 1.7% | - | -2.9% | 0.8% | -1.3% | - |
| Return on invested capital | - | - | -5.4% | 0.1% | 1.1% | - | -2.6% | -0.8% | -0.2% | - |
| Liquidity | ||||||||||
| Current ratio | 3.62 | 5.38 | 5.08 | 2.21 | 5.26 | 5.16 | 6.24 | 11.67 | 15.46 | 15.68 |
| Quick ratio | 1.97 | 4.15 | 3.73 | 1.36 | 4.42 | 4.85 | 5.84 | 11.30 | 14.74 | 14.14 |
| Cash ratio | 0.25 | 3.00 | 2.95 | 0.73 | 3.99 | 4.54 | 5.39 | 9.90 | 13.18 | 13.26 |
| Leverage | ||||||||||
| Debt / Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Debt / Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Debt / EBITDA | - | - | - | 0.43 | 0.25 | - | - | - | 0.00 | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.12 | 1.09 | 1.11 | 1.27 | 1.21 | 1.21 | 1.18 | 1.13 | 1.10 | 1.10 |
| Liabilities / Assets | 0.11 | 0.08 | 0.10 | 0.21 | 0.17 | 0.17 | 0.16 | 0.11 | 0.09 | 0.09 |
| Efficiency | ||||||||||
| Asset turnover | 0.05 | - | 0.11 | 0.22 | 0.18 | - | 0.08 | 0.10 | 0.10 | - |
| Inventory turnover | 0.26 | - | 0.80 | 1.13 | 1.16 | - | 2.06 | 4.12 | 3.08 | - |
| Days sales outstanding | 131d | - | 80d | 88d | 103d | - | 119d | 181d | 136d | - |
| Days inventory outstanding | 1417d | - | 459d | 323d | 315d | - | 177d | 89d | 119d | - |
| Days payable outstanding | 622d | - | 230d | 273d | 253d | - | 222d | 104d | 73d | - |
| Cash conversion cycle | 926d | - | 309d | 139d | 165d | - | 74d | 165d | 182d | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | 0.0x | 0.0x | 0.0x | - |
| P / B | 9.4x | - | 9.4x | 6.3x | 7.3x | - | - | - | - | - |
| P / S | 176.6x | - | 77.3x | 22.6x | 33.9x | - | - | - | - | - |
| EV / EBITDA | - | - | - | 779.0x | 341.8x | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 0.0% | - | 259.4% | 274.1% | 147.2% | - | 4.6% | 12.4% | 28.1% | - |
| Revenue CAGR (3y) | 46.8% | - | 52.3% | 43.2% | 25.0% | - | 5.7% | 7.3% | 31.2% | - |
| Revenue CAGR (5y) | 41.1% | - | 53.9% | 46.0% | 32.1% | - | 6.3% | 4.4% | 2.9% | - |
| Gross profit growth (YoY) | -53.2% | - | 372.9% | 212.3% | 188.2% | - | - | 207.1% | - | - |
| Operating income growth (YoY) | - | - | -481.9% | - | - | - | 53.7% | - | - | - |
| Net income growth (YoY) | - | - | -557.1% | -10.5% | - | - | 55.8% | - | 60.0% | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | 15.7% | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | -850.7% | - | - | - | -667.0% | - | - | - | 88.3% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 304.7% | 392.8% | 185.6% | 45.9% | 28.3% | 12.1% | -13.6% | -16.4% | -18.2% | -19.9% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$39.26M totalAntimony Segment$35.90M · 91.4%
Zeolite Segment$3.36M · 8.6%
Product / service
$39.26M totalAntimony$35.38M · 90.1%
Zeolite$3.36M · 8.6%
Precious Metals$519.9K · 1.3%
Geographic
$39.26M totalUS$38.12M · 97.1%
CA$1.14M · 2.9%
Peer comparison
Same SIC group: Primary Smelting & Refining of Nonferrous Metals
| Company | Revenue (last FY) | Net margin | ROE |
|---|---|---|---|
| SDST | - | - | 270.5% |
Comparing UNITED STATES ANTIMONY CORP against the 1 most active filer in the same SIC group.